White Paper
Shifting Cost-Sharing Burden to Beneficiaries in Medicare Part D
June 19, 2025
Featured Experts: Erin Trish, PhD
Research
All Research Featured Research
News
Why Do Americans Pay More for Prescription Drugs?
June 12, 2025
Featured Experts: Darius Lakdawalla, PhD
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Testimony
Testimony on IRA Implementation’s Threat to Medicine
May 20, 2025
Featured Experts: Erin Trish, PhD
News
Pharmacies Excluded from Preferred Networks Face Much Higher Risk of Closure
May 5, 2025
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
Journal Article
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014–23
May 5, 2025
Featured Experts: Genevieve P. Kanter, PhD, Dima M. Qato, PharmD, MPH, PhD
Perspective
‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems
April 14, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
A Missed Chance to Make America Healthier and Richer
April 7, 2025
Featured Experts: Alison Sexton Ward, PhD, Dana Goldman, PhD
White Paper
Lifetime Social Returns From Expanding Access to Anti-Obesity Medications
March 27, 2025
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Darius Lakdawalla, PhD, Dana Goldman, PhD
News
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
February 18, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
White Paper
The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?
February 18, 2025
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
Cost Sharing for Preferred Branded Drugs in Medicare Part D
February 14, 2025
Featured Experts: Erin Trish, PhD
News
Medicare Beneficiaries Face Much Higher Drug Costs as Plans Quickly Shift to Coinsurance
February 14, 2025
Featured Experts: Erin Trish, PhD
Perspective
Medicare Drug Price Negotiations Need Something New: A Floor
January 22, 2025
Featured Experts: Darius Lakdawalla, PhD
Perspective
Medicare Should Cover Wegovy — But Not Negotiate Its Price
January 17, 2025
Featured Experts: Joseph Grogan, JD
Journal Article
The Inflation Reduction Act and Patient Costs for Drugs to Treat Heart Failure
October 29, 2024
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Perspective
I’m a Doctor in East L.A. and Beverly Hills. I Want to Treat Obesity the Same Way in Both Places
October 28, 2024
Featured Experts: Anne Peters, MD
Testimony
Testimony on the Role of Pharmacy Benefit Managers
September 11, 2024
Featured Experts: Karen Van Nuys, PhD
News
PBM Market Concentration Varies Among Payer Types
September 10, 2024
Featured Experts: Karen Van Nuys, PhD, Dima M. Qato, PharmD, MPH, PhD